We performed a GWAS in a population-based sample without hereditary polyneuropathies to focus on common variants (MAF > 1%), instead of whole exome sequencing (WES) that focuses on rare variants within MME. Furthermore, we did not use molecular genetic testing to detect nucleotide repeat expansions in RFC1 (32). This evidence concerns the gene RFC1 and polyneuropathy.